Literature DB >> 21148803

Lineage divergence at the first TCR-dependent checkpoint: preferential γδ and impaired αβ T cell development in nonobese diabetic mice.

Ni Feng1, Patricia Vegh, Ellen V Rothenberg, Mary A Yui.   

Abstract

The first TCR-dependent checkpoint in the thymus determines αβ versus γδ T lineage fate and sets the stage for later T cell differentiation decisions. We had previously shown that early T cells in NOD mice that are unable to rearrange a TCR exhibit a defect in checkpoint enforcement at this stage. To determine if T cell progenitors from wild-type NOD mice also exhibit cell-autonomous defects in development, we investigated their differentiation in the Notch-ligand-presenting OP9-DL1 coculture system, as well as by analysis of T cell development in vivo. Cultured CD4 and CD8 double-negative cells from NOD mice exhibited major defects in the generation of CD4 and CD8 double-positive αβ T cells, whereas γδ T cell development from bipotent precursors was enhanced. Limiting dilution and single-cell experiments show that the divergent effects on αβ and γδ T cell development did not spring from biased lineage choice but from increased proliferation of γδ T cells and impaired accumulation of αβ T lineage double-positive cells. In vivo, NOD early T cell subsets in the thymus also show characteristics indicative of defective β-selection, and peripheral αβ T cells are poorly established in mixed bone marrow chimeras, contrasting with strong γδ T as well as B cell repopulation. Thus, NOD T cell precursors reveal divergent, lineage-specific differentiation abnormalities in vitro and in vivo from the first TCR-dependent developmental choice point, which may have consequences for subsequent lineage decisions and effector functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148803      PMCID: PMC4087166          DOI: 10.4049/jimmunol.1002630

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

1.  Fine tuning of TCR signaling by CD5.

Authors:  H S Azzam; J B DeJarnette; K Huang; R Emmons; C S Park; C L Sommers; D El-Khoury; E W Shores; P E Love
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

Review 2.  A positive look at double-negative thymocytes.

Authors:  Rod Ceredig; Ton Rolink
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

3.  A defect in central tolerance in NOD mice.

Authors:  H Kishimoto; J Sprent
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

4.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

Authors:  B Salomon; D J Lenschow; L Rhee; N Ashourian; B Singh; A Sharpe; J A Bluestone
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

5.  Low rate of proliferation in immature thymocytes of the non-obese diabetic mouse maps to the Idd6 diabetes susceptibility region.

Authors:  M L Bergman; C Penha-Gonçalves; K Lejon; D Holmberg
Journal:  Diabetologia       Date:  2001-08       Impact factor: 10.122

Review 6.  Branching out to gain control: how the pre-TCR is linked to multiple functions.

Authors:  A M Kruisbeek; M C Haks; M Carleton; A M Michie; J C Zúñiga-Pflücker; D L Wiest
Journal:  Immunol Today       Date:  2000-12

7.  Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage Thymocytes.

Authors:  Anita Wolfer; Anne Wilson; Mohamed Nemir; H Robson MacDonald; Freddy Radtke
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

Review 8.  Regulation of thymocyte differentiation: pre-TCR signals and beta-selection.

Authors:  Alison M Michie; Juan Carlos Zúñiga-Pflücker
Journal:  Semin Immunol       Date:  2002-10       Impact factor: 11.130

9.  Evidence that gammadelta versus alphabeta T cell fate determination is initiated independently of T cell receptor signaling.

Authors:  J Kang; A Volkmann; D H Raulet
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

10.  Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes.

Authors:  Sylvie Lesage; Suzanne B Hartley; Srinivas Akkaraju; Judith Wilson; Michelle Townsend; Christopher C Goodnow
Journal:  J Exp Med       Date:  2002-11-04       Impact factor: 14.307

View more
  7 in total

Review 1.  Forging T-Lymphocyte Identity: Intersecting Networks of Transcriptional Control.

Authors:  Ellen V Rothenberg; Jonas Ungerbäck; Ameya Champhekar
Journal:  Adv Immunol       Date:  2015-10-26       Impact factor: 3.543

Review 2.  Developmental gene networks: a triathlon on the course to T cell identity.

Authors:  Mary A Yui; Ellen V Rothenberg
Journal:  Nat Rev Immunol       Date:  2014-08       Impact factor: 53.106

Review 3.  Transcriptional control of early T and B cell developmental choices.

Authors:  Ellen V Rothenberg
Journal:  Annu Rev Immunol       Date:  2014-01-22       Impact factor: 28.527

4.  Loss of T cell progenitor checkpoint control underlies leukemia initiation in Rag1-deficient nonobese diabetic mice.

Authors:  Mary A Yui; Ni Feng; Jingli A Zhang; Chen Yee Liaw; Ellen V Rothenberg; Jeffrey A Longmate
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

5.  Genetic Variation in Type 1 Diabetes Reconfigures the 3D Chromatin Organization of T Cells and Alters Gene Expression.

Authors:  Maria Fasolino; Naomi Goldman; Wenliang Wang; Benjamin Cattau; Yeqiao Zhou; Jelena Petrovic; Verena M Link; Allison Cote; Aditi Chandra; Michael Silverman; Eric F Joyce; Shawn C Little; Klaus H Kaestner; Ali Naji; Arjun Raj; Jorge Henao-Mejia; Robert B Faryabi; Golnaz Vahedi
Journal:  Immunity       Date:  2020-02-11       Impact factor: 31.745

6.  Thymic negative selection is functional in NOD mice.

Authors:  Michael Mingueneau; Wenyu Jiang; Markus Feuerer; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2012-02-13       Impact factor: 14.307

Review 7.  Cohesin-Mediated Chromatin Interactions and Autoimmunity.

Authors:  Venkataragavan Chandrasekaran; Nina Oparina; Maria-Jose Garcia-Bonete; Caroline Wasén; Malin C Erlandsson; Eric Malmhäll-Bah; Karin M E Andersson; Maja Jensen; Sofia T Silfverswärd; Gergely Katona; Maria I Bokarewa
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.